active movement of chloride drives fluid secretion into the sweat duct. In CF the component of this secretion which is stimulated by /?-adrenergic agents is absent [10] . As the fluid passes along the sweat duct active sodium absorption occurs with the passive accompaniment of chloride. Again, in CF the chloride impermeability of the duct epithelia prevents this movement and in turn, that of the accompanying sodium [11] .
In normal human airway epithelia the bulk of ion flow is that of absorption of sodium from the lumenal surface, probably accompanied by chloride and water moving passively through pathways between cells. These cells can also transport chloride from their submucosal surface towards the airway lumen with sodium and water again the likely accompanying molecules. Both in-vivo [12] and in-vitro [13] studies suggest that in CF the lumenal border of these epithelial cells is impermeable to chloride ions. Additionally Knowles et al. [14] have shown that the sodium absorption across these cells in CF is roughly twice normal. Whether this is a secondary response to the chloride impermeability or directly related to the genetic defect remains to be determined. However, both of these electrolyte abnormalities will tend to reduce the degree of hydration of the airways liquid, perhaps contributing to the thick secretions characteristic of CF. Although there have been fewer studies of ion transport in the pancreas, a similar picture of reduced anion secretion has been suggested [15] .
The intracellular control of chloride secretion in airway epithelia is now under close scrutiny. Using patch-clamp techniques the activity of individual ion channels within the lumenal membrane of these cells can be studied. Agents such as ^-agonists which activate the cAMP second messenger system cause the Cl channel to open in normal epithelium [16] . In CF however, despite a normal rise in intracellular cAMP [16] , and in turn a normal activation of the cAMP-dependent protein kinase [17, 18] , chloride channel opening cannot be elicited. A similar lack of a /3-response in CF submandibular acinar cells has also been shown by McPherson etal. [19] .
Two practical aspects have emerged from these pathophysiological considerations. Related to the abnormal chloride transport in CF is the finding of a markedly more negative potential difference across the respiratory [20] and sweat duct epithelium [21] in these patients. A technique for the measurement of nasal potential difference is being evaluated as a possible means of diagnosis in CF [22] . Secondly, drugs which alter ion transport processes may be of value in the treatment of CF. Amiloride is a well known inhibitor of sodium transport in many epithelia and would be of theoretical benefit in CF by inhibiting the noted increase in sodium and perhaps water absorption. Clinical trials are presently under way with initial reports suggesting a small improvement in mucociliary clearance [23, 24] .
It is to be hoped that the two approaches described above will lead to similar conclusions regarding the basic defect in CF. However, from the patient's viewpoint such optimism will be tempered by the likely lengthy delay between any such discovery and the availability of specific therapy.
